Browsing by Author Mehta V

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
2020Alzheimer�s disorder: Epigenetic connection and associated risk factorsSharma V K; Mehta V; Singh T G
2021CNS implications of COVID-19: A comprehensive reviewNagu P; Parashar A; Behl T; Mehta V
2020Distinctive evidence involved in the role of endocannabinoid signalling in parkinson�s disease: A perspective on associated therapeutic interventionsBehl T; Kaur G; Bungau S; Jhanji R; Kumar A; Mehta V; Zengin G; Brata R; Hassan S.S.U; Fratila O.
2021Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated parkinson�s diseaseKaur G; Behl T; Bungau S; Kumar A; Uddin M S; Mehta V; Zengin G; Mathew B; Shah M A; Arora S
2020Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritisKaur I; Behl T; Bungau S; Kumar A; Mehta V; Setia D; Uddin M.S; Zengin G; Aleya L; Arora S.
2021Integrating Endocannabinoid Signalling In DepressionRana T; Behl T; Sehgal A; Mehta V; Singh S; Kumar R; Bungau S
2021Molecular insights into the therapeutic promise of targeting HMGB1 in depressionRana T; Behl T; Mehta V; Uddin M S; Bungau S
2020Nutraceuticals in neurological disordersMakkar R; Behl T; Bungau S; Zengin G; Mehta V; Kumar A; Uddin M.S; Ashraf G.M; Abdel-Daim M.M; Arora S; Oancea R.
2020Restoration of the attenuated neuroprotective effect of ischemic postcon-ditioning in diabetic mice by sglt inhibitor phlorizinMehta V; Kumar A; Jaggi A S; Singh N
2020Ubiquitination in rheumatoid arthritisBehl T; Chadha S; Sachdeva M; Kumar A; Hafeez A; Mehta V; Bungau S.